

Can't find Aprepitant (Emend)? Here are the best alternatives for preventing chemotherapy-induced nausea, including Akynzeo, Varubi, and other NK1 antagonists.
If your pharmacy can't fill your Aprepitant prescription — whether due to a stock-out, supply issue, or cost concern — you still have options. Several other medications work in similar ways to prevent nausea and vomiting from chemotherapy and surgery.
In this guide, we'll explain what Aprepitant does, how it works, and walk you through the best alternatives your doctor may consider.
Aprepitant (brand name Emend) is a prescription medication used to prevent nausea and vomiting caused by chemotherapy (called CINV — chemotherapy-induced nausea and vomiting) and surgery (called PONV — postoperative nausea and vomiting).
It belongs to a drug class called NK1 receptor antagonists. These medications are a key part of the anti-nausea regimen for patients receiving highly emetogenic (high-nausea-risk) chemotherapy. Aprepitant is typically prescribed alongside other anti-nausea medications like Ondansetron (Zofran) and Dexamethasone.
For a complete overview, see our article on what Aprepitant is, its uses, and dosage.
Aprepitant blocks substance P — a natural chemical in your body — from binding to neurokinin-1 (NK-1) receptors in the brain. These receptors play a major role in triggering the vomiting reflex, especially the delayed nausea that happens 24 hours or more after chemotherapy.
By blocking this pathway, Aprepitant reduces both the immediate and delayed phases of chemotherapy-induced nausea. It also works on NK-1 receptors in the gut, further reducing nausea signals sent to the brain.
Learn more in our detailed article on how Aprepitant works.
Akynzeo is a combination medication that contains two anti-nausea drugs in one pill:
This means Akynzeo covers two anti-nausea pathways in a single dose, which can simplify your treatment. It's taken as one capsule about 1 hour before chemotherapy, alongside Dexamethasone.
Pros:
Cons:
Rolapitant (brand name Varubi) is another NK1 receptor antagonist, but with some key differences from Aprepitant:
Pros:
Cons:
Fosaprepitant is actually the IV prodrug of Aprepitant — your body converts it into Aprepitant after injection. If you can't find oral Aprepitant capsules, this is the most direct alternative.
Many oncology clinics stock Fosaprepitant and can administer it during your chemotherapy session. Ask your oncologist about this option.
While Ondansetron is not in the same drug class as Aprepitant (it's a 5-HT3 receptor antagonist), it's the most commonly prescribed anti-nausea medication and is often already part of your chemotherapy regimen.
If Aprepitant is unavailable, your doctor may adjust your Ondansetron dose or add other supportive medications to compensate. Ondansetron is:
However, Ondansetron alone may not be as effective as the combination of Ondansetron + Aprepitant, especially for preventing delayed nausea from highly emetogenic chemotherapy.
If you can't find Aprepitant, here's what to tell your doctor:
Before switching to an alternative, it's worth checking if Aprepitant is available nearby. Use Medfinder to search real-time pharmacy stock in your area. You might find that a pharmacy just a few miles away has it on the shelf.
Also try:
For more tips, read our guide on how to find Aprepitant in stock near you.
Not being able to fill your Aprepitant prescription is stressful — especially when you're facing chemotherapy. But there are real, effective alternatives available. Akynzeo, Rolapitant, Fosaprepitant, and adjusted Ondansetron regimens can all help prevent chemotherapy-induced nausea and vomiting.
Talk to your oncologist about which option is best for your situation. And don't hesitate to use Medfinder to check availability and pricing for any of these medications.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.